EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer - Christopoulos, Petros; Endris, Volker; Bozorgmehr, Farastuk; El Sayed, Mei; Kirchner, Martina; Ristau, Jonas; Buchhalter, Ivo; Penzel, Roland; Herth, Felix; Heußel, Claus Peter; Eichhorn, Martin E.; Muley, Thomas; et al. (International journal of cancer, 2018)
First published: 24 January 2018